ATP III

(redirected from Adult Treatment Panel III)

ATP III

Adult Treatment Panel III. A brief overview of the National Cholesterol Education Program’s (NCEP) updated clinical guidelines for detecting, evaluating, and treating high cholesterol in adults.
Summary ATP III recommends that all adults above age 20 should get a fasting baseline lipoprotein profile every 5 years.
Rationale The profile is a parameter which, like diabetes, hypertension and other “traditional” heart disease risk factors, serves as a basis for determining the intensity of risk-reducing interventions.
Mentioned in ?
References in periodicals archive ?
The study's primary outcomes were measured using the Framingham risk algorithm to assess the 10-year risk of having a cardiovascular event and the Adult Treatment Panel III diagnostic criteria to assess for metabolic syndrome.
8 million more people than would have been treated according to the older Adult Treatment Panel III (ATP-III) guidelines (3).
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Control : Virtual patients were evaluated for therapy for elevated LDL-C and treated with statins to standard LDL-C goals, in accordance with the National Cholesterol Education Program Adult Treatment Panel III (ATP III) guidelines.
As part of its national lipid treatment guidelines, the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) has included non-HDL as a secondary goal of therapy.
Such patients would not be recommended for statin therapy according to Adult Treatment Panel III guidelines.
This is consistent with current guidelines from the American Diabetes Association(4) and the National Cholesterol Education Program Adult Treatment Panel III.
According to the National Cholesterol Education Program's Adult Treatment Panel III report, there are seven factors that contribute to metabolic syndrome.
CHICAGO -- Psychiatrists need to understand that the operational details of monitoring cardiometabolic status in patients on antipsychotics--a task they are now expected to perform--are already spelled out in national guidelines, including the National Cholesterol Education Program Adult Treatment Panel III and the American Diabetes Association/American Psychiatric Association consensus guidelines.
2) The rate of achieving the LDL-C goal of The National Cholesterol Education Program (NCEP) in Adult Treatment Panel III (ATP III) in the combination therapy group was 73.
The group included 591 people (28%) who met the criteria for metabolic syndrome of the Adult Treatment Panel III guidelines of the US.

Full browser ?